Authors

• Takuro Isoda
• Kensuke Mitsunari (ORCID: https://orcid.org/0000-0002-6963-5632)
• Maki Fujiwara (ORCID: https://orcid.org/0000-0002-6354-2638)
• Kousei Ishigami (ORCID: https://orcid.org/0000-0001-8107-5570)
• Shusuke Akamatsu (ORCID: https://orcid.org/0000-0002-1394-7506)
• Takashi Kobayashi
• Hideki Enokida
• Toshiyuki Kamoto
• Katsuyoshi Higashijima
• Masatoshi Eto
• Tsukasa Igawa
• Shoji Tokunaga
• Masaki Shiota
• Tomomi Kamba
• Hirotsugu Uemura
• Naoya Masumori
• Hiroji Uemura
• Takayuki Sumiyoshi

Institutions

• Kurume University (JP)
• Kagoshima University (JP)
• University of Miyazaki (JP)
• Kyushu University (JP)
• Sapporo Medical University (JP)
• University of Occupational and Environmental Health Japan (JP)
• Kyoto University (JP)
• Yokohama City University Medical Center (JP)
• Ehime University Hospital (JP)
• Nagasaki University (JP)
• Nagoya University (JP)
• Yokohama City University (JP)
• Kindai University (JP)
• Kumamoto University (JP)

Publication Details

Journal

Journal of Nuclear Medicine

Published

2026-04-16

DOI

https://doi.org/10.2967/jnumed.126.272073

Primary Topic

Prostate Cancer Treatment and Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• AstraZeneca
• Sanofi
• Astellas Pharma
• Bayer Yakuhin